Clinical trial
Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria
NCT00493727 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00493727 |
|---|---|
| Title | Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria |
| Official title | Use of Mucomyst (NAC) to Ameliorate Oxidant Stress in Diabetic Patients as Measurable by Surrogate Serum Markers |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | West Virginia University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes, Proteinuria |
| Intervention type | Drug |
| Interventions | N-acetylcysteine(Mucomyst) |
| Enrollment | 15 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 28, 2007 |
| Last update posted | May 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: